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Objective: Obesity is strongly linked to genes regulating neuronal signaling and function, implicating the central nervous system in the
maintenance of body weight and energy metabolism. Genome-wide association studies identified significant associations between body mass
index (BMI) and multiple loci near Cell adhesion molecule2 (CADM2), which encodes a mediator of synaptic signaling enriched in the brain. Here
we sought to further understand the role of Cadm2 in the pathogenesis of hyperglycemia and weight gain.
Methods: We first analyzed Cadm2 expression in the brain of both human subjects and mouse models and subsequently characterized a loss-of-
function mouse model of Cadm2 for alterations in glucose and energy homeostasis.
Results: We show that the risk variant rs13078960 associates with increased CADM2 expression in the hypothalamus of human subjects.
Increased Cadm2 expression in several brain regions of Lepob/ob mice was ameliorated after leptin treatment. Deletion of Cadm2 in obese mice
(Cadm2/ob) resulted in reduced adiposity, systemic glucose levels, and improved insulin sensitivity. Cadm2-deficient mice exhibited increased
locomotor activity, energy expenditure rate, and core body temperature identifying Cadm2 as a potent regulator of systemic energy homeostasis.
Conclusions: Together these data illustrate that reducing Cadm2 expression can reverse several traits associated with the metabolic syndrome
including obesity, insulin resistance, and impaired glucose homeostasis.
 2017 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The central nervous system is widely known to regulate energy
expenditure and hormone sensitivity; however, the full extent to which
our metabolism is managed by the brain and the key genes involved
remain to a large degree unknown [1,2]. Recent studies have begun to
identify neurons in regions of the brain beyond the hypothalamus
which engage circuitry of the arcuate nucleus and mediate effects on
energy balance [3]. While neuron-specific disruption of the insulin and
leptin receptors both significantly influence body mass and glucose
homeostasis, these key signaling mediators are widely expressed
throughout the brain including the hippocampus, cerebral cortex, and
cerebellum, indicating that the role of many independent sub-
populations in energy homeostasis remains to be described [4e6].
Moreover, it has long been established that both insulin and leptin are
released systemically in proportion to body fat mass; however it is of
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by identifying molecular determinants which contribute to both
signaling cascades [7].
Cadm2 (also known as SynCAM2, Igsf4d, and Nectin-like molecule 3)
has been shown to be enriched throughout the central nervous
system, and forms oligomers via its extracellular domain [8]. As
immunoglobulin domain-containing adhesion proteins, Cadm2 and its
related family members, including Cadm1, have been established to
mediate the assembly of pre-synaptic specializations in neurons in
the brain to direct homo- and heterophilic interactions across the
nascent and mature synaptic cleft [9]. Genome-wide association
studies meta-analysis for body mass index (BMI) recently identified
several susceptibility loci which associate with body mass index and
map near genes known to function in the central nervous system
including CADM1 and CADM2 [10e12]. We recently showed
neuronal Cadm1 regulates body weight and energy homeostasis via
its expression within the hippocampus and hypothalamus [13]. Hereerlin, Germany 2Helmholtz Zentrum München, Institute of Computational Biology,
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we illustrate loss of Cadm2 protects mice from obesity and hyper-
glycemia by regulating locomotor activity and thermogenesis further
underlining the functional role of this gene family in systemic energy
homeostasis via the brain.
2. MATERIALS AND METHODS
2.1. Animals
Mice were housed in groups of 3e5 animals and maintained on a 12-
hour light/dark cycle with ad libitum access to regular chow food or
high fat diet (containing 60% kcal fat, cat. no. E15741-347, ssniff
Spezialdiäten GmbH), in accordance with the Landesamt für
Gesundheit und Soziales (LAGeSo). All experimental procedures were
approved under protocols G 0216/16, G 0357/10, G 0204/14, O 0405/
09, and T 0436/08. Cadm2KO mice were generated by the trans-NIH
Knock-Out Mouse Project (KOMP) and obtained from the KOMP Re-
pository (www.komp.org). Cadm2KO mice were characterized after
backcrossing for four generations to C57BL/6 and then crossed to
Lepob/ob mice (Jackson Labs). Results were consistent in both genders;
however, data from female mice is not shown.
2.2. Analytic procedures
2.2.1. Quantification of metabolic parameters
Blood glucose levels were obtained with the One Touch glucometer
(Bayer) and plasma insulin measurements were measured by ELISA as
described (Crystal Chem) [14].
2.2.2. Antibodies for western blot analysis
The following primary antibodies were used for western blotting at
1:1000 dilution: Cadm1 (MBL CM004-3), Cadm2 (Synaptic systems,
243203), UCP-1 (Cell Signaling, #14670), STAT3 (Cell Signaling,
#9139), p-STAT3 (Cell Signaling, #4113), TH (Cell Signaling, #2792),
b-Actin (Sigma, A1978), GAPDH (Abcam, ab8245), a-Tubulin (Sigma,
T6557). Variance in the banding patterns of Cadm proteins in different
panels may result from variation in acrylamide percentage or levels of
protein glycosylation. Image densitometry of 16-bit TIF images for all
western blots was performed using ImageJ.
2.2.3. Primary cell cultures
Primary neurons were derived from hippocampi of mice at age post-
natal day 2 and dissected in cold HBSS (Invitrogen), followed by
digestion with papain. After centrifugation, tissue pellet was resus-
pended in Neurobasal (Invitrogen) supplemented with B27 (Invitrogen)
and Glutamax (Invitrogen) for plating. Hippocampal cells were cultured
in 24-well dishes with 12 mm coverslips (5000 cells per coverslip)
coated with poly-D-lysine and laminin and immunohistochemistry was
performed as described previously [15]. After post-fixation in 4% PFA,
sections were blocked with 10% BSA/PBS, then incubated with pri-
mary antibody overnight at 4 C, followed by the fluorochrome-
conjugated secondary antibodies for 1 h. Fluorescence was imaged
under a confocal microscope (Zeiss LSM700). Digital images were
analyzed with Fiji/ImageJ.
2.3. Mouse phenotyping
All phenotyping analysis was performed in a ‘blinded’ manner; ge-
notypes were unknown to the investigator during the experimentation
and age of animals is stated in figure legends. All genotypes were
present during all experiments and randomization was implemented
to the extent that all animals were identified by number prior to
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analysis
Body temperature was measured by rectal probe thermometry at
ambient room temperature. Body composition analysis was measured
using Minispec Model LF90 II (6.5 mHz) (Bruker Instruments). VO2,
VCO2, food intake, and locomotor activity were measured using the
PhenoMaster System (TSE, Germany), and energy expenditure was
analyzed as previously described using ANCOVA [16]. Animals were
placed into individual cages with weight sensors quantifying ad libitum
access to food. VO2 and VCO2 level were measured for 1 min in a 9 min
interval for 4 consecutive days and locomotor activity was measured
continuously by breaks of light beams. The first 24 h of measuring time
was excluded from the analysis to allow for acclimation to the new
cage environment. Measurement of energy expenditure was normal-
ized to lean body mass as previously described [13].
2.3.2. Tolerance tests
Glucose and pyruvate tolerance tests were performed following an
overnight fast (16 h) and injected intraperitoneally with either glucose
(2 g/kg body weight) or pyruvate (2 g/kg body weight in saline) as
described [14]. Insulin tolerance tests were performed after same day
fast (6 h) by injecting insulin (Sigma) intraperitoneally (0.75 U/kg body
weight). Murine leptin (Peprotech) (0.75 mg/g body weight) was
injected intraperitoneally twice daily (09:00 and 19:00) for 3 days.
Body weight and food intake were measured daily at 08:30.
2.4. eQTL analysis
We have downloaded currently unpublished eQTL data from the GTEx
consortium analysis version 6, including results from ten distinct brain
regions [17]. We specifically queried the data for association tests that
were performed for the gene CADM2 against SNP rs13078960. We
adjusted for multiple hypothesis testing using the method of Benjamini
and Hochberg required false discovery rate (FDR) below 15% to call
associations significant [18]. Boxplots were obtained through the GTEx
portal.
2.5. Statistical analysis
All results are expressed as mean  standard error (SEM), and sta-
tistical analysis is summarized in Supplementary Table 1. Comparisons
between data sets with two groups were evaluated using an unpaired
Student’s t-test. One-way and two-way repeated-measures ANOVA
analysis has been performed using GraphPad Prism Software Version
7 for comparisons of three or more groups. Post hoc statistics were
performed using Sidak’s multiple comparison test. A P-value of less
than or equal to 0.05 was considered statistically significant. The
presented data met the assumptions of the statistical tests used.
Normality and equal variances were tested using GraphPad Prism
software. No statistical methods were used to pre-determine sample
sizes but our sample sizes are similar to those reported in previous
publications [13].
3. RESULTS
3.1. SNP associates with increased CADM2 in human subjects
Recent genome-wide association studies (GWAS) identified a single
nucleotide polymorphism (SNP) (rs13078960) in proximity to CADM2,
which associates with increased body mass index (BMI) in human
subjects [12]. We analyzed expression quantitative trait locus (eQTL)
data from 10 distinct regions of the brain available from the GTEx
consortium and observed that this risk allele (the allele associated with
increased BMI) is associated with increased expression of its proximalen access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 181
Original Articlegene in the multiple brain regions of human subjects: CADM2 (caudate
basal ganglia (P ¼ 0.0018), putamen basal ganglia (P ¼ 0.0009),
cerebellum (P ¼ 0.0045), and hypothalamus (P ¼ 0.0467))
(Figure 1AeD) [19]. We note that the lead SNP rs13078960 is in strong
linkage disequilibrium (R2¼ 0.99 in 1000 genomes) with rs13078807,
which has been identified in an independent cohort previously [12] and
likely tags a shared haplotype containing the antisense transcript
CADM2-AS2 (Figure 1E).Figure 1: BMI risk SNPs associate with increased CADM2 expression in several brain
gene expression levels (y-axis), solid horizontal lines indicate the median, and whiskers ind
risk allele (G) of rs13078960 in caudate basal ganglia, putamen basal ganglia, cerebellum,
levels in human brain. E, Plot showing the linkage disequilibrium (R2) in the 1000 genomes
SNPs in a region around the lead SNP plotted against the position of the SNP (x-axis). Gene
the arrows ‘>’ and ‘<’ next to the gene symbols. Regulatory elements annotated by
recombination rate, which is shown as light blue line. Color-coding of each SNP reflects the
in [12].
182 MOLECULAR METABOLISM 8 (2018) 180e188  2017 The Authors. Published by Elsevier GmbH. T3.2. Cadm2 mediates leptin sensitivity
Consistent with our eQTL analysis, we observed increased Cadm2
protein levels in the hypothalamus of mice on high-fat diet for 20
weeks compared to lean chow-fed, littermate controls (Figure 2A).
These results coincide with our earlier study showing increased
Cadm2 expression in several brain regions of obese and insulin-
resistant ob/ob mice (Lepob/ob) [13]. Together these observations
further support that increased expression of Cadm2 in the human andregions of human subjects. Boxplots show the 25% and 75% quantiles of normalized
icate the 10% and 90% quantiles. A-D, Elevated expression of CADM2 associates with
and hypothalamus, respectively. The risk allele (G) is associated with higher expression
population between the lead SNP rs13078960 (blue box) [12] on the (left) y-axis for all
s locations are shown as green horizontal lines. The strand of each gene is indicated by
the SNIPa webserver [25] are indicated as blue lines. The right y-axis indicates the
strength of linkage disequilibrium. The SNP highlighted in blue is the lead SNP identified
his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 2: Loss of Cadm2 expression results in decreased body weight and improved leptin sensitivity. A, Western blot analysis of Cadm2 and Cadm1 in total lysates from
hypothalamus of wild-type mice on normal chow diet and littermate controls on high fat diet (HFD) feeding. B, Western blot analysis of Cadm2 in brain, pancreas, intestine, liver,
BAT, WAT, muscle, heart in the wild-type mice. C, Western blot analysis of Cadm2 expression in wild-type brain from 1 week to 15 weeks. D, Representative confocal images of
Cadm1 and Cadm2 expression in VGLUT2-positive primary hippocampal neurons. Immunostaining for Cadm1 (red), Cadm2 (green), and VGLUT2 (cyan) identify points of co-
localization in dendritic branch (white arrows). E, Representative confocal images of Cadm1 and Cadm2 expression in VGAT-positive primary hippocampal neurons. Immuno-
staining for Cadm1 (red), Cadm2 (green), and VGAT (cyan) identify points of co-localization in dendritic branch (white arrows). F, Western blot analysis of Cadm1 and Cadm2 in total
and synaptosome-enriched lysates from hypothalamus of 12-week-old Cadm2KO mice and littermate controls. G, Body weight curves of Cadm2KO mice (n ¼ 9) and littermate
controls (n ¼ 19). H, Quantification of food intake and body weight change in 11-week old Cadm2KO (n ¼ 4) and littermate controls (n ¼ 4) during leptin challenge. Daily food
intake and body weight was measured for 5 days prior to leptin administration for base line. I, Western blot analysis of STAT3 phosphorylation in the hypothalamus of Cadm2KO
and wild-type (WT) littermates after leptin injection (0.75 mg/g body weight). p-STAT3, phosphorylated STAT3. J, Western blot analysis of Cadm1, Cadm2, and p-STAT3 in the
hypothalamus of 12-week-old wild-type mice, Lepob/ob mice after 5 days PBS or leptin injection. Results are presented as mean  SEM. *P < 0.05.
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Original Articlemouse brain associates with elevated body weight and indicate that
this gene plays a significant role in maintaining energy balance.
Analysis by western blotting indicates that the brain is the highest site
of expression, and Cadm2 levels are stable from birth through post-
natal development (Figure 2B and C). Interestingly, administration of
the high fat diet also incurred an increase in BAT and skeletal muscle;
however it is not known in which cell type Cadm2 is present within
these tissues (Supplementary Figure 1A). Within primary hippocampal
neurons, we observed that Cadm2 co-localizes with its related family
member Cadm1 in both glutamatergic and GABAergic neurons in vitro
(Figure 2D and E).
We previously showed that global loss-of-function of Cadm2 in mice
(Cadm2KO mice) resulted in decreased body weight and improved
insulin sensitivity and energy expenditure rate (Figure 2F and G) [13].
Similar to global loss-of-function of Cadm1 in mice, Cadm2KO animals
exhibited lower body weight and food intake in comparison to litter-
mate control mice after intraperitoneal administration of leptin
(Figure 2H and Supplementary Figure 1B). Leptin treatment also
resulted in increased hypothalamic expression of phosphorylated-
STAT3 in Cadm2KO mice, further indicating that total loss of Cadm2
expression resulted in increased leptin sensitivity (Figure 2I). Lastly,
intraperitoneal administration of leptin to obese and insulin-resistant
ob/ob mice (Lepob/ob) reversed the increased hypothalamic expres-
sion of Cadm2, suggesting expression of this protein is regulated by
this hormone and impacts the downstream effects of this signaling
pathway (Figure 2J and Supplementary Figure 1C). These results
further underline the relevance of Cadm2 to body weight regulation,
and we next evaluated the contribution of this gene to weight gain in a
mouse model of obesity and hyperglycemia.
3.3. Loss of Cadm2 protects from obesity and diabetes
In light of the increased expression of Cadm2 in several brain regions
of mouse models of both genetically and diet-induced obesity, we
crossed Cadm2KO mice onto the Lepob/ob background (Cadm2/ob) and
observed lower body mass, circulating random glucose, and plasma
insulin levels compared to Lepob/ob littermates (Figure 3AeD). We next
performed insulin, glucose, and pyruvate tolerance tests (ITT, GTT, and
PTT, respectively) and observed lower glucose levels in Cadm2/ob
mice in comparison to littermate controls indicating systemic insulin
sensitivity was improved (Figure 3EeG). To address whether the en-
ergy expenditure rates were altered in Cadm2/ob animals, we quan-
tified O2 consumption, CO2 production, energy expenditure, and
locomotor activity, and all were higher in Cadm2-deficent mice, while
nutrient partitioning (based on respiratory exchange rate (RER)) was
normal (Figure 3HeK). Cadm2/ob exhibited a reduction in fat mass and
evaluation of energy expenditure using analysis of covariance
(ANCOVA), as plotted in relation to lean body mass, confirmed the
increased expenditure rates in Cadm2-deficient animals compared to
littermate Lepob/ob mice (Figure 3L and M) [16]. When energy expen-
diture was plotted in relation to locomotor activity, this comparison
showed that these parameters are not significantly correlated sug-
gesting several factors may contribute to the role of Cadm2 in energy
homeostasis (Figure 3N). Additionally, loss of Cadm2 did not affect
food intake of Lepob/ob mice compared to littermate controls
(Figure 3O). We observed increased hypothalamic expression of
phosphorylated-STAT3 in Cadm2/ob mice, indicating loss of Cadm2
can impact this signaling cascade even in the absence of leptin
(Figure 3P). Lastly, after administration of high fat diet, Cadm2-defi-
cient mice exhibited reduced body weight and improved insulin
sensitivity and glucose tolerance in comparison to control littermates
(Figure 3QeS). Together these results indicate loss of Cadm2184 MOLECULAR METABOLISM 8 (2018) 180e188  2017 The Authors. Published by Elsevier GmbH. Tprotected mice from both genetically and diet-induced obesity and
insulin resistance by improving energy homeostasis and insulin
sensitivity independent of any change in food intake.
3.4. Cadm2 regulates thermogenesis and energy metabolism
To further understand the underlying causes for the decrease in body
weight, we next measured the core body temperature of Cadm2/ob
mice and observed a higher mean temperature compared to littermate
Lepob/ob animals (Figure 4A). Additionally, inguinal white adipose tissue
(ingWAT) and liver mass were both lower in Cadm2/ob mice, indicating
Cadm2 contributes body mass by regulating systemic energy meta-
bolism (Figure 4B). Consistent with increased core body temperature,
Ucp1 expression in BAT was higher in Cadm2/ob animals compared to
littermate Lepob/ob mice (Figure 4C). Meanwhile, expression of tyrosine
hydroxylase (TH), a marker for noradrenergic parenchymal nerve
fibers, was also higher in Cadm2/ob mice compared to littermate
Lepob/ob mice and correlates with both thermogenesis and an increase
in activity of the sympathetic nerves of this fat depot (Figure 4C).
Histological analysis of interscapular brown adipose tissue (BAT) from
Cadm2/ob mice revealed a reduction in lipid accumulation compared
to Lepob/ob littermates in line with increased energy expenditure in this
tissue (Figure 4D). Consistent with these observations, gene expres-
sion analysis showed several genes enriched in BAT (including Ucp1,
Acadl, Prdm16, Pgc1a, Cidea, Acadm, Cox8b, Cox6a1, and Cox17) are
decreased in Lepob/ob mice compared to littermate controls. Mean-
while, the expression of these genes in the BAT of Cadm2/ob is
significantly increased in comparison to Lepob/ob littermates, indicating
Cadm2 contributes to the expression of these BAT-selective genes
(Figure 4D). The restoration of expression of these BAT-selective genes
in Cadm2/ob mice indicates loss of Cadm2 can reverse weight gain by
promoting thermogenesis and energy expenditure in BAT [9e20].
Histological analysis of WAT tissue suggests a similar reduction in lipid
storage; however, expression analysis in WAT of many of these BAT-
enriched genes was unaltered in Cadm2/ob in comparison to Lepob/ob
littermate mice, indicating loss of Cadm2 does not impact browning in
this fat depot (Figure 4E). Lastly, image analysis of liver also shows
loss of Cadm2 reverses lipid accumulation in liver (Figure 4F). Gene
expression analysis in liver for markers of gluconeogenesis (G6pc and
Pck), glucose metabolism (Gck and Slc2a2), lipogenesis (Fas, Acc1,
and Scd1), and ketogenesis (Hmgcs2 and Fgf21) showed increased
expression in Lepob/ob mice compared to wild-type littermates was
reversed in the livers of Cadm2/ob mice.
4. DISCUSSION
It is now widely known that the brain is a central regulator of body
weight and systemic energy metabolism; however, the precise cellular
mechanisms and pathways mediating energy homeostasis remain to
be fully elucidated [2]. This effort has been aided by genome-wide
association studies, which continue to implicate genes enriched in
the central nervous system in the susceptibility to obesity [12]. Here we
illustrate the association of the risk variant rs13078960 with increased
CADM2 expression in multiple brain regions of human subjects which
further underlines the link between CADM genes and weight gain [13].
These observations importantly coincide with our results in mouse
models of obesity showing increased hypothalamic expression of both
Cadm2 and its related family member Cadm1. Interestingly, we
showed that the increased expression of Cadm1 and 2 in this region is
reversed by leptin treatment, suggesting that specific subpopulations
within the brain may maintain a complex dynamic with their metabolic
environment by altering the expression of these cell adhesion proteins.his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 3: Cadm2-deficient mice are protected from genetic obesity. A, Western blot analysis of Cadm1 and Cadm2 in total and synaptosome-enriched lysates from hy-
pothalamus of 12-week-old Lepob/ob mice and Cadm2/ob. B, Body weight in male Cadm2/ob mice (n ¼ 8), Lepob/ob mice (n ¼ 13) and littermate controls (WT, n ¼ 19) from 4 to 16
weeks of age. C, Random and fasting glucose measurements in 16-week-old Cadm2/ob mice, Lepob/ob mice and littermate controls (n ¼ 3e7). D, Plasma insulin measurements in
16-week-old Cadm2/ob mice, Lepob/ob mice and littermate controls (n ¼ 3e6). E, Glucose measurements during an insulin tolerance test on 12-week old Cadm2/ob mice, Lepob/ob
mice and littermate controls (n ¼ 4e6). F, Glucose measurements during a glucose tolerance test on 11-week old Cadm2/ob mice, Lepob/ob mice and littermate controls (n ¼ 4e
6). G, Glucose measurements during pyruvate tolerance test on 12-week old Cadm2/ob mice, Lepob/ob mice and littermate controls (n ¼ 4e6). H-K, Quantification of O2
consumption, CO2 production, RER, and locomotor activity in 12-week old Cadm2/ob mice and Lep
ob/ob mice (n ¼ 6e8). L, Body composition analysis of male Cadm2/ob mice and
Lepob/ob mice (n ¼ 6e9). M, Energy expenditure of individual animals plotted against lean body mass from 12-week old Cadm2/ob mice (n ¼ 6) and Lepob/ob mice (n ¼ 8). N,
Energy expenditure of individual animals plotted against locomotor activity from 12-week old Cadm2/ob mice (n ¼ 6) and Lepob/ob mice (n ¼ 8). O, Quantification of daily food
intake of Cadm2/ob mice (n ¼ 6) and Lepob/ob mice (n ¼ 8). P, Western blot analysis of STAT3 phosphorylation in the hypothalamus of Cadm2/ob mice and Lepob/ob mice after
leptin injection (0.75 mg/g body weight). p-STAT3, phosphorylated STAT3. Q, Body weight in male Cadm2 mice and littermate controls (WT) from 5 to 20 weeks of age (n ¼ 6e9).
High fat diet feeding was initiated on 4 weeks old. R, Glucose measurements during an insulin tolerance test on 21-week old Cadm2 mice and littermate controls (n ¼ 6e9). High
fat diet feeding was initiated on 4 weeks-old. S, Glucose measurements during a glucose tolerance test on 22-week old Cadm2 mice and littermate controls (n ¼ 6e9). High fat
diet feeding was initiated on 4 weeks-old. Results are presented as mean  SEM. *P < 0.05, **P < 0.01 and ***P < 0.001.We previously showed that increased expression of Cadm1 and Cadm2
in several brain regions of Lepob/ob mice could be restored by
administration of a ketogenic diet, further strengthening the notion that
these genes are sensitive to changes in the physiologic state. The
administration of leptin and ketogenic diet both result in reduced
consumption of glucose and the lowering of body weight in Lepob/ob
mice further implicating Cadm proteins in energy homeostasis.
As mediators of synapse formation and morphology, the modulatory
nature of Cadm proteins in response to leptin may suggest theyMOLECULAR METABOLISM 8 (2018) 180e188  2017 The Authors. Published by Elsevier GmbH. This is an op
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that impact body weight and adiposity may be transient [9]. The effects
of leptin may allude to previous studies by Biederer and colleagues
identifying Cadm proteins as regulators of synaptic plasticity and
network excitation [21,22]. Future studies may determine that Cadm
proteins ‘fine-tune’ cell signaling according to changes in metabolic
state and its expression in several brain regions ‘coordinate’ pathways
that contribute to systemic energy homeostasis. In light of the effect on
leptin sensitivity, the increase in the expression of Cadm proteins in theen access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 185
Figure 4: Increased thermogenesis in Cadm2-deficient Lepob/ob mice. A, Core body temperature in 12-week-old mice (n ¼ 4e16). B, Inguinal WAT (ingWAT) and liver mass
in 12-week-old mice (n ¼ 3e5). C, Western blot analysis of interscapular BAT extracts from 12-week-old wild-type (WT), Lepob/ob mice and Cadm2/ob mice using antibodies
against Cadm2, Ucp1, tyrosine hydroxylase (TH) and a-tubulin. DeF, Haematoxilin and eosin staining of interscapular BAT, ingWAT, and liver and qRT-PCR gene expression
analysis from 12-week-old wild-type (WT), Lepob/ob mice and Cadm2/ob mice (n ¼ 3e6). Results are presented as mean  SEM. *P < 0.05, **P < 0.01 and ***P < 0.001.
Original Articlebrain may also suggest that these synaptic proteins in addition to their
interacting partners contribute to leptin resistance in the brain. To date,
it is unclear whether the expression of Cadm proteins reflects changes
in systemic glucose levels or whether their function is relevant to
specific glucose-sensing neurons. It should also be noted that the
impact of loss of Cadm2 on body weight was greater on the Lepob/ob
background in comparison to the high fat diet challenge, further
suggesting the physiologic role of Cadm2 overlaps with leptin-sensitive
pathways. As leptin has been long known to impact the development of
neuronal circuits within the arcuate nucleus, it is plausible that the
deletion of Cadm2 or its related proteins impacts the early network
organization regulating energy expenditure and behaviors affecting
systemic metabolism [23].
We previously showed loss of Cadm1 impacted inhibitory post-
synaptic currents of POMC neurons in addition to the number of
excitatory synaptic contacts that project to this population [13]. Given
this, future studies should determine whether the functional role of
Cadm2 in energy homeostasis is also mediated by POMC neurons. In
light of our observations showing increased expression of Cadm1 and
2 in several brain regions of human subjects, it is possible that Cadm
proteins within multiple cellular networks spread across the brain act186 MOLECULAR METABOLISM 8 (2018) 180e188  2017 The Authors. Published by Elsevier GmbH. Tin a coordinated manner in the context of energy expenditure. Future
experiments should also address the function of Cadm proteins in
regions recently implicated in the regulation of energy metabolism
including the cerebellum, hindbrain, brainstem, and amygdala [24]. In
the absence of the identification of other neurons in addition to POMC
neurons potently regulating energy expenditure, it is reasonable to
hypothesize that information from multiple circuits ‘funnel’ into the
arcuate nucleus and ultimately to POMC neurons to impact energy
homeostasis. Likewise, it is also possible that independent circuits
may function ‘in parallel’ and drive separate and specific mechanisms
(i.e. thermogenesis, locomotor activity, insulin sensitivity, hepatic
glucose production), contributing to energy homeostasis. Lastly, Cadm
proteins are present in non-neuronal cell-types of the brain (i.e. oli-
godendrocytes, astrocytes) and their specific contributions within each
of these subpopulations should be determined in the context of energy
homeostasis. The functional role of Cadm proteins in systemic phys-
iology has been shown to be complex and given the robust association
of several risk variants with the increased expression of CADM genes
in the brain of human subjects, understanding their role in diverse
circuits will undoubtedly provide new insight into the pathways driving
energy homeostasis in the brain.his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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5. CONCLUSIONS
To date, multiple SNPs in proximity to the CADM2 gene have now been
shown to associate with both increased BMI and increased expression
of CADM2 in several brain regions of human subjects thereby estab-
lishing its potential role in human obesity. Our observations using
mouse models show reducing Cadm2 expression in Lepob/ob mice will
reverse the hyperglycemia, insulin resistance, and adiposity and
further underlines the relevance of studying the Cadm gene family in
the context of metabolic diseases. Improving our understanding of
Cadm proteins in synaptic organization and physiology within the brain
may facilitate mapping of distinct cellular networks that regulate en-
ergy metabolism. In summary, these observations on Cadm2 identify it
as a potent regulator of insulin and leptin sensitivity in addition to
energy homeostasis and provide insight into the mechanisms under-
lying the progression of diabetes and obesity.
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